Table 1.
Demographic and clinical characteristics of subjects.
| Stable COPD group | AECOPD group | P | |
|---|---|---|---|
|
| |||
| N | 18 | 31 | NS |
| Age (y) | 63.6 (11.3) | 68.6 (10.4) | .85 |
| Gender (male/female) | 15/3 | 26/5 | .63 |
| BMI (kg/m2) | 21.4 (5.2) | 18.7 (5.7) | .91 |
| GOLD stage (I+II) | 10 | 19 | .69 |
| GOLD stage (III+IV) | 8 | 12 | .69 |
| Ischemic heart disease (n) | 4 | 10 | .45 |
| Diabetes | 5 | 15 | .16 |
| Osteoporosis | 3 | 6 | .81 |
| Length of hospitalization (median, days) | --- | 11.8 (4.6) | NS |
| Antibiotic treatment (n, %) | --- | 27 (87.1%) | NS |
| White blood cell count (109/L) | 7.72 (1.9) | 9.3 (2.5) | <.01 |
| pH | --- | 7.3 (0.1) | NS |
| PaCO2 (mm Hg) | --- | 53.7 (20.0) | NS |
| PaO2 (mm Hg) | --- | 70.0 (10.5) | NS |
| hs CRP (mg/L) | 5.3 (1.9) | 8.0 (3.1) | <.01 |
| PCT (μg/L) | 0.3 (0.1) | 0.49 (0.2) | <.01 |
| nCD64 (%) | 1.50 (0.5) | 2.84 (1.0) | <.01 |
Values are mean (standard deviation). Statistically significant values are bolded.